These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12078337)

  • 1. [Clinical investigation of hyaluronidase and nerve growth factor (NGF) at the ocular level: detailed review of the international literature].
    Melino G; Vitale L; Abetti P; Bossi A; Fabbri T; Saracino V; Capozza G
    Clin Ter; 2002; 153(2):119-26. PubMed ID: 12078337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of hyaluronic acid and hyaluronidase in ocular pathology].
    KOVALEV DS
    Vestn Oftalmol; 1957; 70(3):40-4. PubMed ID: 13456215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ocular diseases in public health].
    Comi R; Di Vito Mucedola C
    Ann Ig; 2003; 15(6):1037-49. PubMed ID: 15049561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis.
    Lee HK; Lee KS; Kim HC; Lee SH; Kim EK
    Am J Ophthalmol; 2005 Jun; 139(6):965-71. PubMed ID: 15953424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension.
    Rudzinski M; Wong TP; Saragovi HU
    J Neurobiol; 2004 Feb; 58(3):341-54. PubMed ID: 14750147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ascorbic acid in the treatment of eye diseases].
    Mozherenkov VP; Agafonov BV
    Oftalmol Zh; 1980; 35(2):117-9. PubMed ID: 6995889
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of hyaluronic acid and hyaluronidase in eye disease].
    KOVALEV DS
    Vestn Oftalmol; 1956; 69(4):12-3. PubMed ID: 13381043
    [No Abstract]   [Full Text] [Related]  

  • 8. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases.
    Micera A; Lambiase A; Aloe L; Bonini S; Levi-Schaffer F; Bonini S
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):411-7. PubMed ID: 15561599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of balance of hyaluronic acid and hyaluronidase in pathogenesis of certain vesicular diseases].
    FOLDVARI F; NEKAM L
    Borgyogy Venerol Sz; 1955 Mar; 9(2):38-43. PubMed ID: 14389389
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of ocular complications of leprosy in institutionalized patients in NWFP Pakistan.
    Khan T; Awan AA; Kazmi HS; Shah AA; Muhammad S; Muhammad S
    J Ayub Med Coll Abbottabad; 2002; 14(4):29-33. PubMed ID: 12688099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for neurotrophin treatment of the ocular surface following laser in situ keratomileusis (LASIK)?
    Pepose JS; Johnson EM
    Am J Ophthalmol; 2005 Jun; 139(6):1090-4. PubMed ID: 15953442
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular-weight-based hyaluronidase assay using fluorescent hyaluronic acid as a substrate.
    Nagata H; Kojima R; Sakurai K; Sakai S; Kodera Y; Nishimura H; Inada Y; Matsushima A
    Anal Biochem; 2004 Jul; 330(2):356-8. PubMed ID: 15203344
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptococcal hyaluronidase. II. Studies on the production of hyaluronidase and hyaluronic acid by representatives of all types of hemolytic streptococci belonging to group A.
    FABER V; ROSENDAL K
    Acta Pathol Microbiol Scand; 1954; 35(2):159-64. PubMed ID: 13197034
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the system hyaluronidase-hyaluronic acid in physiology and pathology].
    ZABŁOCKI B
    Postepy Hig Med Dosw; 1953; 7(1-2):30-64. PubMed ID: 13194421
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium: I. Ocular and systemic metabolism.
    Yolton DP
    J Am Optom Assoc; 1983 Feb; 54(2):129-34. PubMed ID: 6841867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous serum application in the treatment of neurotrophic keratopathy.
    Matsumoto Y; Dogru M; Goto E; Ohashi Y; Kojima T; Ishida R; Tsubota K
    Ophthalmology; 2004 Jun; 111(6):1115-20. PubMed ID: 15177961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular manifestations of rickettsial diseases].
    Bourla N; Alhalel A
    Harefuah; 2005 Nov; 144(11):772-3, 823. PubMed ID: 16358650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh.
    Nutheti R; Shamanna BR; Nirmalan PK; Keeffe JE; Krishnaiah S; Rao GN; Thomas R
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4742-8. PubMed ID: 17065482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between hyaluronidase and hyaluronic acid in pemphigus and Duhring's disease.
    SZODORAY L
    Borgyogy Venerol Sz; 1955 Mar; 9(2):44-6. PubMed ID: 14389390
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of changes in the enzyme-salt composition affecting the permeability of ocular tissues under infrasound phonophoresis].
    Filatov VV
    Vestn Oftalmol; 2005; 121(3):26-8. PubMed ID: 16075626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.